The section introduces the "Cannabinoid Safety and Regulation Act," which is designed to ensure safety and regulate cannabinoid products. It outlines various parts of the Act, including how the Food and Drug Administration will regulate cannabinoid products, efforts to collect public health data, initiatives to prevent underage cannabis use, and programs to address cannabis-impaired driving.

The text describes regulations for cannabinoid products, including their manufacturing, labeling, and distribution requirements under the Cannabinoid Safety and Regulation Act. It outlines the establishment of a Center for Cannabinoid Products, rules against adulterated or misbranded products, registration protocols for facilities, safety and testing standards, and how these products align with federal and state laws.

The bill requires the creation of a new Center for Cannabinoid Products within the Food and Drug Administration (FDA) no later than 120 days after the Cannabis Safety and Regulation Act is enacted. This center will handle tasks related to the act and coordinate with the FDA Commissioner like other FDA divisions.

A cannabinoid product is considered adulterated if it contains harmful substances, is made or stored in unsanitary conditions, or its container is made of dangerous materials. Additionally, it is deemed adulterated if the manufacturing does not meet certain standards, inspections are hindered, or it contains unsafe color additives or synthetic cannabinoids.

A cannabinoid product is considered misbranded if its labeling or advertising is misleading, if it lacks specific information such as a clear label about its cannabinoid content and manufacturer details, or if it resembles products marketed toward children. Additionally, it must comply with various other regulations, such as not imitating common candies or beverages and ensuring safety and health warnings are included.

Covered entities, which are businesses handling cannabinoid products, must register their facilities with the Secretary within specific timeframes and renew registrations every two years, providing detailed information about their operations. The Secretary can set a registration fee, develop a system for product identification, and suspend registration if safety concerns arise, with the option for facilities to appeal and correct issues; all submitted registration information is protected from public disclosure unless legally required.

The section outlines regulations for controlling cannabinoid products, including age restrictions on their sale, labeling requirements, and packaging standards. It also addresses testing and manufacturing practices to ensure product safety and compliance, permitting foods and dietary supplements to contain cannabinoids, and offers guidance on producing synthetic cannabinoids to protect public health.

The section outlines standards for cannabinoid products, requiring the Secretary to set regulations within a year to ensure public health safety. These standards cover ingredients, testing, labeling, sale restrictions, and require both foreign and domestically grown cannabinoids to meet the same criteria; they must also be periodically reviewed for updates based on new data.

If the Secretary believes a cannabinoid product could cause serious harm, they can order its distribution to stop immediately and later decide if a recall is needed. The order allows those involved to argue against it, but if upheld, the Secretary will set a recall schedule and communicate the risks to the public, possibly with the help of retailers.

Each manufacturer or importer of cannabinoid products must keep detailed records and report any actions to correct issues or remove products from the market if these changes are needed to protect health or comply with regulations. However, they do not have to report actions if the information has already been submitted as required in another part of the law.

Any electronic device that delivers cannabis products is prohibited from having added artificial or natural flavors, like fruit or spice flavors, according to the proposed law. However, such devices can include terpenes, which are naturally occurring compounds, as long as they make up a small percentage of the product's total weight.

In this section, the bill clarifies that federal, state, Tribal, and local governments can enforce their own laws about cannabinoid products, as long as they don't conflict with specific rules about labeling and transportation. It also confirms that existing product liability laws aren't changed by these new rules, and it doesn't affect the Department of Agriculture's authority over hemp cultivation.

The amendments to the Federal Food, Drug, and Cosmetic Act clarify definitions related to cannabis and cannabinoid products, establish restrictions on their sale and use, address violations and penalties, and add regulatory oversight for their manufacture, distribution, and import/export. The text specifies new terminologies, such as what constitutes cannabis and cannabinoids, prohibits selling cannabinoid products containing THC to those under 21, and outlines penalties for non-compliance with new regulations.

The section mandates that, within 60 days of the new law being passed, several top government officials must collaboratively create a report. This report should propose how to regulate cannabinoid drinks with THC, similar to alcohol, and clearly outline each agency's role in handling labeling, taxes, production, and safety standards for these beverages.

The amendment to Section 392A of the Public Health Service Act expands its focus to include the adverse health effects of cannabis and polysubstance use. It increases funding to $596 million annually for 2024 to 2028 and provides an additional $100 million per year to support research and data collection on these topics.

The text outlines a new section of the Public Health Service Act where the Secretary will provide funding through grants, contracts, and cooperative agreements to various entities to prevent underage cannabis use. The funds aim to support programs, education, and collaboration efforts, especially in underserved communities, with a total of $25 million available each year from 2024 to 2028.

The section outlines a program where the Secretary, through the Assistant Secretary, will grant funds to eligible entities, like states, tribes, and nonprofits, to prevent and reduce underage cannabis use. These funds support programs and strategies for education, community collaboration, and treatment services, and preference will be given to communities with high rates of underage use or disproportionate cannabis-related convictions.

The section defines key terms used in the legislation, clarifying that "Administrator" refers to the head of the National Highway Traffic Safety Administration, "cannabis" includes both the plant and cannabinoid products, "Secretary" means the Secretary of Transportation, and "THC" stands for tetrahydrocannabinol.

The bill section focuses on researching cannabis-impaired driving by collecting relevant data, conducting a National Roadside Survey, and carrying out a study to examine the risks and effects of driving under the influence of cannabis alone or with other substances. Reports summarizing findings and conclusions are to be submitted to various Senate and House committees as mandated.

The section mandates that the Secretary create strategies and campaigns to educate people about the dangers of driving under the influence of cannabis, especially for those under 21. It also requires regular evaluation and reporting to Congress on the effectiveness of these campaigns.

The section establishes a federal grant program administered by the National Highway Traffic Safety Administration to help states prevent cannabis-impaired driving. States can receive these grants if they follow federal guidelines, use the funds for specific activities like enforcement and education, and share data on the effectiveness of their efforts.

The bill establishes a program to provide grants to states to prevent cannabis-impaired driving by supporting enforcement, data collection, and education activities. Funding is allocated with a federal share that decreases over time for states not implementing an open container law related to cannabis, with $40 million appropriated annually from 2024 to 2028.

The section requires the Secretary to decide within three years if a national standard for cannabis-impaired driving can be created, and to reevaluate this every two years. If creating such a standard is possible, the Secretary must propose rules for a model standard for states within a year after making that determination.

In Section 306, an additional $30 million is allocated for each fiscal year from 2024 to 2029. This money is meant to support the activities described in sections 302 and 303.